Christian Jackisch
Goethe University Frankfurt(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)Sana Klinikum Offenbach(DE)Kliniken Essen-Mitte(DE)NSABP Foundation(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, BRCA gene mutations in cancer
Most-Cited Works
- → Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer(2005)5,074 cited
- → Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes(2012)2,632 cited
- → Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer(2018)2,536 cited
- → Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy(2017)2,068 cited
- → Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers(2014)1,018 cited
- → 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial